Ashi Pharmaceuticals Private Limited
About Ashi Pharmaceuticals Private Limited
Data last updated:
Ashi Pharmaceuticals Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2010PTC024392. Its GSTIN is 23AAICA8422B1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashwini Kumar Batra and Prem Batra.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shop No. 8 Amma Market 97 Sanvind Nagar Kanadia Road, Indore, Madhya Pradesh, India – 452018.
As per the financials filed for FY 2019, the company reported a revenue of ₹36.95 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹19,833 (net margin -0.5%) and EBITDA of ₹4.44 Lakh (EBITDA margin 12%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ashi Pharmaceuticals Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 8 Amma Market 97 Sanvind Nagar Kanadia Road, Indore, Madhya Pradesh, India – 452018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ashi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ashi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ashi Pharmaceuticals Private Limited, buy the company report.
Financials of Ashi Pharmaceuticals Private Limited
FY 2019 filings availableAshi Pharmaceuticals Private Limited reported revenue of ₹36.95 Lakh (down 11% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over three years, including a 11% fall in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.44 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19,833 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12% | ||||
| Net Profit Margin | -0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ashi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ashi Pharmaceuticals Private Limited
Ashi Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwini Kumar Batra | Director | 23 Sep 2010 | 16 Years 1 Months | Current |
| Prem Batra | Director | 10 Oct 2010 | 16 Years 0 Months | Current |
Peer comparison
Ashi Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BLJ Pharmaceuticals Private Limited | ₹37.07 Lakh (FY 2025) | 1530.0% | Dadri, Uttar Pradesh, India | |||
| Serene Health Care Private Limited | ₹36.97 Lakh (FY 2024) | -96.0% | Ahmedabad, Gujarat, India | |||
| Ashi Pharmaceuticals Private Limitedthis company | ₹36.95 Lakh (FY 2019) | -₹19,833 | -0.5% | -11.0% | Indore, Madhya Pradesh, India | |
| Cardion Biotech Private Limited | ₹36.81 Lakh (FY 2025) | 200.0% | Dehradun, Uttarakhand, India |
To see the full peer comparison of Ashi Pharmaceuticals Private Limited, buy the company report.
Auditor
Ashi Pharmaceuticals Private Limited is audited by S N KABRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S N KABRA & CO | FY 2018 | 003439C |
Shareholding
The shareholding of Ashi Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ashi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ashi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ashi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ashi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICA8422B1Z6 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ashi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ashi Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Santosh Dabhade ceased to be Director on 15 May 2019.
Frequently asked questions
Ashi Pharmaceuticals is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 September 2010 (16+ years old) and is registered under CIN U24232MP2010PTC024392.
Ashi Pharmaceuticals has 2 current directors:
- Ashwini Kumar Batra - Director
- Prem Batra - Director
The latest financial statements of Ashi Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
The GSTIN of Ashi Pharmaceuticals is 23AAICA8422B1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ashi Pharmaceuticals is U24232MP2010PTC024392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ashi Pharmaceuticals was incorporated on 23 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ashi Pharmaceuticals by revenue are BLJ Pharmaceuticals Private Limited, Serene Health Care Private Limited, Cardion Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Santosh Dabhade ceased to be Director on 15 May 2019. Vinay Chaudhary ceased to be Director on 30 Mar 2011. Prem Batra was appointed as Director on 10 Oct 2010. Ashi Pharmaceuticals has 4 board changes on record in total.
The registered office of Ashi Pharmaceuticals is at Shop No. 8 Amma Market 97 Sanvind Nagar Kanadia Road, Indore, Madhya Pradesh, India – 452018.
Ashi Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ashi Pharmaceuticals is compliant as of 03 July 2026. The company is actively filing with the Registrar of Companies.